Annual EBIT:
-$98.85M-$25.87M(-35.45%)Summary
- As of today, JANX annual earnings before interest & taxes is -$98.85 million, with the most recent change of -$25.87 million (-35.45%) on December 31, 2024.
- During the last 3 years, JANX annual EBIT has fallen by -$65.92 million (-200.18%).
- JANX annual EBIT is now -2521.24% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$35.25M+$9.87M(+21.87%)Summary
- As of today, JANX quarterly earnings before interest & taxes is -$35.25 million, with the most recent change of +$9.87 million (+21.87%) on September 30, 2025.
- Over the past year, JANX quarterly EBIT has increased by +$591.00 thousand (+1.65%).
- JANX quarterly EBIT is now -4167.68% below its all-time high of -$826.00 thousand, reached on March 31, 2020.
Performance
JANX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$144.29M+$591.00K(+0.41%)Summary
- As of today, JANX TTM earnings before interest & taxes is -$144.29 million, with the most recent change of +$591.00 thousand (+0.41%) on September 30, 2025.
- Over the past year, JANX TTM EBIT has dropped by -$58.33 million (-67.85%).
- JANX TTM EBIT is now -17368.28% below its all-time high of -$826.00 thousand, reached on March 31, 2020.
Performance
JANX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JANX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -35.5% | +1.6% | -67.8% |
| 3Y3 Years | -200.2% | -95.6% | -131.6% |
| 5Y5 Years | -2521.2% | -2706.6% | -4426.0% |
JANX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -200.2% | at low | -155.0% | +21.9% | -131.6% | +0.4% |
| 5Y | 5-Year | -2521.2% | at low | -2706.6% | +21.9% | -4426.0% | +0.4% |
| All-Time | All-Time | -2521.2% | at low | -4167.7% | +21.9% | >-9999.0% | +0.4% |
JANX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$35.25M(+21.9%) | -$144.29M(+0.4%) |
| Jun 2025 | - | -$45.12M(-29.3%) | -$144.88M(-27.6%) |
| Mar 2025 | - | -$34.90M(-20.2%) | -$113.58M(-14.9%) |
| Dec 2024 | -$98.85M(-35.4%) | -$29.02M(+19.0%) | -$98.85M(-15.0%) |
| Sep 2024 | - | -$35.84M(-159.3%) | -$85.96M(-30.4%) |
| Jun 2024 | - | -$13.82M(+31.4%) | -$65.93M(+9.5%) |
| Mar 2024 | - | -$20.16M(-24.9%) | -$72.86M(+0.2%) |
| Dec 2023 | -$72.98M(-8.8%) | -$16.14M(-2.0%) | -$72.98M(+2.8%) |
| Sep 2023 | - | -$15.81M(+23.8%) | -$75.11M(+2.9%) |
| Jun 2023 | - | -$20.75M(-2.3%) | -$77.32M(-4.7%) |
| Mar 2023 | - | -$20.28M(-11.0%) | -$73.83M(-10.0%) |
| Dec 2022 | -$67.09M | -$18.27M(-1.4%) | -$67.09M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.02M(-4.4%) | -$62.31M(-12.9%) |
| Jun 2022 | - | -$17.26M(-27.5%) | -$55.20M(-24.9%) |
| Mar 2022 | - | -$13.54M(-0.4%) | -$44.19M(-34.2%) |
| Dec 2021 | -$32.93M(-400.6%) | -$13.49M(-23.7%) | -$32.93M(-69.4%) |
| Sep 2021 | - | -$10.90M(-74.4%) | -$19.44M(-98.5%) |
| Jun 2021 | - | -$6.25M(-173.7%) | -$9.79M(-110.8%) |
| Mar 2021 | - | -$2.28M(-81.8%) | -$4.65M(-45.7%) |
| Dec 2020 | -$6.58M(-74.4%) | - | - |
| Sep 2020 | - | -$1.26M(-13.6%) | -$3.19M(-65.0%) |
| Jun 2020 | - | -$1.11M(-33.9%) | -$1.93M(-133.9%) |
| Mar 2020 | - | -$826.00K | -$826.00K |
| Dec 2019 | -$3.77M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual EBIT year-on-year change?
- What is Janux Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Janux Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM EBIT year-on-year change?
What is Janux Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of JANX is -$98.85M
What is the all-time high annual EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$3.77M
What is Janux Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, JANX annual earnings before interest & taxes has changed by -$25.87M (-35.45%)
What is Janux Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of JANX is -$35.25M
What is the all-time high quarterly EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$826.00K
What is Janux Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, JANX quarterly earnings before interest & taxes has changed by +$591.00K (+1.65%)
What is Janux Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of JANX is -$144.29M
What is the all-time high TTM EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$826.00K
What is Janux Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, JANX TTM earnings before interest & taxes has changed by -$58.33M (-67.85%)